Infection control practices continue to be scrutinized as our healthcare industry faces an unforeseen public health crisis. The COVID-19 pandemic is forcing healthcare organizations to take quick action to protect patients and staff from potential exposure within their facilities. It’s also prompting leaders to consider how they can bolster infection control processes and train their staff to better prepare for the future.
Even once the coronavirus has been contained, serious infection prevention challenges will remain. Healthcare-associated infections (HAIs) are a serious threat to health systems and their patients, each year impacting two million patients and costing U.S. hospitals $28 billion to $45 billion. As the pandemic subsides, cash-strained providers will be paying even closer attention to preventable costs like HAIs.